-
Interpol seized more than $6.65 million of imitation drugs against malaria, HIV, and tuberculosis in Southeast Asia for the second time in three years. Operation Storm involved almost 200 raids conducted across Cambodia, China, Laos, Myanmar, Singapore, Thailand, and Vietnam. Among the seized medications were fake malaria drugs based on artemisinin, which renders the malaria parasite resistant to
제약단신
메디칼라이터팀
2008.11.19 00:00
-
Roger Bate, the director of the health advocacy group Africa Fighting Malaria, says, in an op-ed in the New York Times, that more must be done to secure the safety and quality of drugs in developing countries. Many poor governments have turned to local production, which is of low-quality. Most of them don’t have regulation to monitor safety nor laws against selling substandard drugs. Aid organizat
제약단신
메디칼라이터팀
2008.11.19 00:00
-
The journal Nature Reviews Drugs Discovery, published in the UK, reports that cancer drug research is entering a new era which will mean more successful drugs for patients. Cancer Research U.K, a charity institution, collected the data on 974 drugs under development of which 18 percent of them will prove successful in clinical trials according to experts.
제약단신
메디칼라이터팀
2008.11.19 00:00
-
An FDA panel said on November 14 that Embeda, a controlled-release form of morphine, has an advantage over other pain medication in the markets in terms of oral administration. Professionals should be aware however of abusers who solve the pills in alcohol and inject the mixture, since the drug"s resistance to abuse was tested only when it was taken by mouth.
제약단신
메디칼라이터팀
2008.11.19 00:00
-
At the Australian Health and Medical Research Congress on November 17, Prof. Ian Frazer, who developed Gardasil, presented a vaccine against the human papilloma virus (HPV), which can be used on children to prevent skin cancer and will be ready within 5 to 10 years. It is unknown yet how many skin cancers are caused by HPV, but generally accepted is that one in 20 of the cancers are caused by the
제약단신
메디칼라이터팀
2008.11.19 00:00
-
CryoCath, which specializes in cryo therapy products used in the treatment of cardiac arrhythmias, was bought out by Medtronic Inc., a medical device company, for $380 million, or $8.75 a share.
제약단신
메디칼라이터팀
2008.11.18 00:00
-
Inotek Pharmaceuticals Corp., a drug developer in Beverly, has been issued two patents for the company"s glaucoma treatment and contrast-induced nephropathy prevention treatment. Both compounds, INO-8875 for glaucoma and INO-4885 for contrast-induced nephropathy, are in Phase 1 clinical development.
제약단신
메디칼라이터팀
2008.11.18 00:00
-
On October 15, the FDA approved a new formulation of azelastine HCl nasal spray (Astepro) by Meda AB, Sweden, for the treatment of seasonal allergic rhinitis in patients 12 years and older.
제약단신
메디칼라이터팀
2008.11.18 00:00
-
A study by the University of Wisconsin in Madison researched the anti proliferative effects of the 2 compounds in multiple human prostate cancer cell lines. Researchers found that vitamin E and selenium alone led to a modest inhibition in the viability and growth of prostate cancer cells, but a combination of the two resulted in a much more marked increase in growth inhibition.
제약단신
메디칼라이터팀
2008.11.18 00:00
-
Merck’s ongoing study with Gardasil, a vaccine to prevent cancers associated with the human papilloma virus (HPV), revealed its ability to reduce the incidence of genital warts. The study enrolled males aged 16 to 23, including 3,400 heterosexuals and 600 homosexuals, who were randomized to either receive three doses of the vaccine or placebo, and were followed every six months for 36 months. The
제약단신
메디칼라이터팀
2008.11.18 00:00
-
Although the latest attempt to develop an AIDS vaccine has failed, new insights have been gained. The role of the foreskin in HIV transmission seems relevant because uncircumcised men who were vaccinated had a higher rate of infection. Also, infection rates were higher among those who had developed immunity to a virus that causes colds, while the HIV vaccine being tested, was developed on the same
제약단신
메디칼라이터팀
2008.11.18 00:00
-
Patients with peripheral arterial disease (PAD) had a 50 percent lower all-cause mortality risk when treated with statins. A research study analyzed data on 681 PAD patients who participated in the Walking and Leg Circulation Study (WALCS). PAD was defined as an ankle-brachial index of less than 0.90. Statin users had a significantly lower all-cause mortality (HR 0.52, P=0.014) and cardiovascular
제약단신
메디칼라이터팀
2008.11.18 00:00
-
Starting in January 2009 clinical trials of a melanoma vaccine will begin at the melanoma unit in Auckland and will include participants from throughout New Zealand. New research shows the country has the highest rate of the cancer in the world.
제약단신
메디칼라이터팀
2008.11.18 00:00
-
AstraZeneca announced November 13 that European regulators have approved a new version of its bipolar disorder drug Seroquel (quetiapine fumarate). Seroquel XR, a once-daily formulation, has been approved for new indications in bipolar disorder and moderate to severe manic episodes in bipolar disorder.
제약단신
메디칼라이터팀
2008.11.18 00:00
-
Although stem-cell technology has primarily been the focus of small biotechnology companies, Pfizer announced that it will spend $100 million in research of stem cells to treat heart disease, diabetes, and vision loss common among the elderly. Also GlaxoSmithKline, Johnson & Johnson, Novartis AG and Roche have begun partnerships or invested in companies developing stem-cell treatments.
제약단신
메디칼라이터팀
2008.11.18 00:00
-
Roche’s Avastin (bevacizumab) in combination with paclitaxel and carboplatin chemotherapy gives an additional 4 months of life to patients with advanced adenocarcinoma, compared to chemotherapy alone. This is the result of the randomised, controlled, multicentre phase III E4599 study of 878 patients with locally advanced, metastatic or recurrent NSCLC, treated with Avastin at a dose of 15 mg/kg ev
제약단신
메디칼라이터팀
2008.11.17 00:00
-
고지혈증치료제에 대한 기등재의약품 평가 결과 반영 방식이 성분별이 아닌 품목별 약가 인하로 가닥이 잡혔다. 최근 제약업계에 따르면 심평원 약제급여평가위원회가 지난 12일 회의를 갖고 이 같은 방침을 결정한 것으로 전해졌다. 이에 따라 기존 심바스타틴을 기준으로 최소 22.6%에서 최대 35.9% 정도의 약가 인하율 적용이 품목별로 다소 다르게 적용될 것으로 전망된다. 즉 올 5월 심평원이 발표한 고지혈증치료제에 대한 경제성평가 결과에 따라 심바스타틴의 가중평균가 838원을 기준으로 품목별로 인하율을 재조정받게 되는 것이다. 이와 관련 이번 평가대상에 품목을 보유한 한 제약업체 관계자는 "종전 인하율 적용 방식에서 품목별로 바뀐 정당한 근거를 모르겠다"고 말하며 "이번 결정에 따른 고시가 이뤄질 경우 매
제약바이오
송병기
2008.11.17 00:00
-
식품의약품안전청 생물의약품국은 최근 식약청 홈페이지(생물의약품국-가이드라인정보)를 통해 2009년도 가이드라인 작성 계획을 공개한다고 밝혔다. 식약청은 이번 가이드라인 발간 예정 목록은 이달 30일까지 외부 이해관계자들의 의견을 반영해 수정할 계획이라며, 12월 말에 확정·공개된다고 했다. 2009년 발간예정 가이드라인은 ▲백신의 독성시험 해설서 ▲헤모필루스인플루엔자비형-단백접합백신의 기준 및 시험방법 작성 가이드라인 ▲백신 임상시험 수행시 이상반응 중증도(Grade) 평가지표 ▲면역글로불린제제의 임상적 유효성 연구를 위한 가이드라인 ▲생물의약품의 제조공정 변경에 따른 비교동등성 가이드라인 ▲재조합의약품의 면역원성 평가에 관한 가이드라인 ▲당단백질의약품의 당구조 특성분석 및 규격관리를 위한 가이드라인 ▲마
제약바이오
김수미 기자
2008.11.17 00:00
-
폴리본 제품 사진. 한미약품(대표 장안수)은 최근 생체재료 개발 전문업체인 경원메디칼과 국내 판권 계약을 체결 합성 인공뼈 제품 폴리본과 골시멘트 옵티본을 출시한다고 밝혔다. 회사측은 이번 판권 계약으로 한미약품이 1천억원 규모의 인공뼈 시장에 본격 진출하게 됐다며, 폴리본은 지난해 미국 FDA승인을 받은 제품으로 시중에 유통되는 인공뼈 제품 중 유일하게 뼈 형성 촉진인자인 폴리포스페이트 성분이 들어 있어 손실된 뼈를 대체하고 뼈 성장을 돕는 특징이 있다고 설명했다. 또 골시멘트 옵티본은 시멘트 형태의 단일 제형으로 지난 2005년 CE 인증을 획득한 제품이라고 덧붙였다. 한미약품 관계자는 기존 임상자료와 별도로 폴리본에 대한 다기관 임상시험을 올해 안에 추가적으로 실시 제품의 효과와 안전성을 다시 한 번
제약바이오
김수미 기자
2008.11.17 00:00
-
광동제약 설문결과 직장인들은 일잘하는 동료를 최고로 꼽았으며, 일주일 중 피로가 심한 날은 월요일이라는 조사 결과가 나왔다. 최근 광동제약과 온라인 리쿠르팅 업체 잡코리아가 서울과 수도권 20~30대 직장인 남녀 1657명을 대상으로 실시한 직장인 풍속도 설문 결과 이같이 나타났다. 이번 조사에서 직장 내에 비타민C같은 동료가 있느냐는 질문에 80.3%의 응답자가 그렇다고 답했으며, 비타민C 같은 동료 유형으로는 업무를 적극 지원하거나 도와주는 동료가 1위(42.3%), 끊임없는 유머로 웃음을 주는 동료가 2위(26.2%)를 차지했다. 3위로는 박학다식한 백과사전형 동료(10.6%)를 4위로 밥이나 술을 잘 사주는 동료와 얼굴만 봐도 피로가 풀리는 꽃미남, 꽃미녀 동료가 공동 4위(각각 6.9%)로
제약바이오
김수미 기자
2008.11.17 00:00